Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer. Field, who ...
Insulet (PODD) Corporation shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational randomized controlled trial were presented at the 18th International ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback